ASSAY OF THE ANTI-OESTROGENIC EFFECTS OF PROGESTAGENS IN WOMEN

Harry W. Rudel, Thomas B. Lebherz, M Maqueotopete, Jorge Martínez-Manautou, Stuart A. Bessler

Reproduction · 1967 · 11 citations · 3 references

DOIFull text

Open access

Concepts

Abstract

Summary. An assay to determine the anti-oestrogenic potency of progestagens in women is described. The progressive increase in endometrial glandular suppression with increasing doses of progestagens is the basis of the assay. Norethindrone (oestrogen free) is three times as potent as chlormadinone acetate with a 95% confidence limit of 2·3 to 4·0. This is in contrast to the greater secretory potency of chlormadinone acetate. It is suggested that the anti-oestrogenic action of progestagens is of some importance in the selection of compounds for contraceptives of the combined progestagen—oestrogen, and of great importance for those of the continuous low dose progestagen types. This property may also be desirable in the treatment of both endometrial hyperplasia and adenocarcinoma.

References

3